Profile_bird

Hey there! Pharmafocus is using Twitter.

Twitter is a free service that lets you keep in touch with people through the exchange of quick, frequent answers to one simple question: What's happening? Join today to start receiving Pharmafocus's tweets.

Already using Twitter
from your phone? Click here.

Pharmafocus

  1. Professor Chris Ham appointed new chief executive of UK health think tank The King’s Fund. http://ow.ly/I4AB
  2. Europe needs a biopharmaceutical innovation fund. Sector suffering from three major funding gaps, says report. http://ow.ly/I4vb
  3. Just Health PR appoints Tamsin Tierney to the newly created role of director. http://ow.ly/I4uG
  4. Boehringer readies coms for new diabetes launch. Weber Shandwick will handle UK PR for linagliptin. http://ow.ly/I4tV
  5. Process R&D lab brings academia and industry together. University of Leeds facility will support 'greener' checmicals. http://ow.ly/I4qb
  6. European shakeup for pharma. Responsibility for EC policy switched from industry to health directorate. http://ow.ly/HNww
  7. Adapt or die. Companies need to evolve faster to remain at the top of global pharmaceutical manufacturing. http://ow.ly/HNe8
  8. Bayer takes Alzheimer's diagnostic into pivotal trials. Imaging agent florbetaben enters phase III testing. http://ow.ly/HKBx
  9. Oxford BioTherapeutics appoints Dr Jim Cornett, Dr Jon Terrett and Dr Mike Gresser to its US R&D operation. http://ow.ly/HKdb
  10. Pharmafile R&D Review out now. Includes Roche's Spanish genome project and French government's biotech initiative. http://ow.ly/Htjo
  11. Building value - is the pipeline all that matters when defining an emerging company's value? http://ow.ly/HsZd
  12. UK faces north/south divide on cancer outcomes. Also regional variation in services, according NHS report. http://ow.ly/HrA8
  13. Digital Pharma: Pfizer launches European YouTube channel. Showcases employees in region and their motivation. http://ow.ly/Hpqt
  14. EU should require all trials be registered, says IQWiG. German agency also criticises Pfizer for concealing data. http://ow.ly/HpmY
  15. Paris-based ExonHit Therapeutics appoints Hervé Duchesne de Lamotte chief financial officer. http://ow.ly/Hpie
  16. Plan to bypass NICE put out for consultation. 'Innovation Pass' due to be launched next year. http://ow.ly/H5vr
  17. Manufacturing news in brief. Includes investments at Servier, Aurobindo and QM Specials, and a reprieve for Dey. http://ow.ly/H48l
  18. Neal Patel to join the Royal Pharmaceutical Society of Great Britain as head of corporate communications. http://ow.ly/H1qJ
  19. Digital Pharma: Byte-sized. Includes ABPI on Twitter, illegal drug websites targeted and Digital Economy Bill. http://ow.ly/GbAj
  20. SHAs: the NHS innovation leaders? Gerard Doherty looks at the influence of strategic health authorities. http://ow.ly/GbxS